Cancer-associated stroke: Pathophysiology, detection and management (Review)

scientific article published on 02 January 2019

Cancer-associated stroke: Pathophysiology, detection and management (Review) is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.3892/IJO.2019.4669
P932PMC publication ID6365034
P698PubMed publication ID30628661

P50authorDimitrios SpandidosQ18701325
Dimitrios P. BogdanosQ48362185
Aristidis TsatsakisQ56852961
Michael AschnerQ64778814
Efthimios DardiotisQ64856630
Vasileios SiokasQ89774601
Athina-Maria AloizouQ102072844
P2093author name stringMassimo Libra
Illana Gozes
Panayiotis D Mitsias
Alexandros G Brotis
Konstantinos Tsarouhas
Athanassios P Kyritsis
Sofia Markoula
Georgios Tzanakakis
P2860cites workCase report: Central nervous system involvement of human graft versus host disease: Report of 7 cases and a review of literatureQ44071531
Craniocerebral involvement in lymphomaQ44107912
The pattern of cancer in a large cohort of stroke patientsQ44507778
Major cerebral infarction from tumor embolusQ44512240
Prior cancer in patients with ischemic stroke: the Bergen NORSTROKE studyQ44711514
Androgen-deprivation therapy and the risk of stroke in patients with prostate cancerQ44765115
Brain tumors with hemorrhageQ44777803
Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia - a multicentre study from the Nordic Society of Paediatric Haematology and OncologyQ44792736
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenQ44833341
Neurologic manifestations of intravascular coagulation in patients with cancer: A clinicopathologic analysis of 12 casesQ44891086
Post-Stroke Cancer Risk among Postmenopausal Women: The Women's Health Initiative.Q45074591
Subdural hematoma in patients with cancer.Q45632323
Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up studyQ46393127
Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiologyQ46414033
Bloodstream infections in patients with or without cancer in a large community hospitalQ46747690
Association of tamoxifen use and reduced cardiovascular events among asian females with breast cancerQ46975337
Increased risk of brain cancer incidence in stroke patients: a clinical case series, population-based and longitudinal follow-up studyQ47556528
Edoxaban for the Treatment of Cancer-Associated Venous ThromboembolismQ47682974
Ischemic stroke in patients with cancer: is it different from usual strokes?Q47688786
Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.Q48125307
Cerebral infarction from non-bacterial thrombotic endocarditis. Clinical and pathological study including the effects of anticoagulationQ48197641
Intravenous alteplase for acute ischemic stroke in patients with current malignant neoplasmQ48211423
Granulocytic sarcoma: an unusual complication of acute promyelocytic leukemia causing cerebellar hemorrhage. Case reportQ48219471
Carotid artery revascularisation following neck irradiation: immediate and long-term resultsQ48222132
Reversible non-thrombotic occlusion of the superior sagittal sinus caused by metastatic malignant lymphoma--case reportQ48224452
The activity of malignancy may determine stroke pattern in cancer patients.Q48334947
Intracerebral hemorrhage caused by a neoplastic aneurysm from small-cell lung carcinoma: case reportQ48370385
Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective studyQ48392373
The thrombotic syndrome associated with carcinoma. A clinical and neuropathologic studyQ48503363
Fatal intracranial hemorrhage after intravenous thrombolytic therapy for acute ischemic stroke associated with cancer-related nonbacterial thrombotic endocarditisQ48602537
Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from SwedenQ48681269
Relationship of endocarditis, disseminated intravascular coagulation, and embolic signals in cancer with strokeQ48693620
Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancerQ48719305
Cerebral hemorrhage due to hyperleukocytosisQ48734462
First-ever stroke as initial presentation of systemic cancerQ49138867
When to Screen Ischaemic Stroke Patients for CancerQ50198318
Leptomeningeal dissemination of malignant glioma simulating cerebral vasculitis. Case report with angiographic and pathological studies.Q52012230
Association of intensive morphine treatment and increased stroke incidence in prostate cancer patients: a population-based nested case–control study.Q52302801
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH.Q53348197
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study.Q53592527
[Leukostasis and tumor lysis: important complications of hyperleukocytosis].Q55057310
American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.Q55488882
Stroke Rates and Risk Factors in Patients Treated With Radiation Therapy for Early-Stage Breast CancerQ57617610
Irradiation-induced extracranial carotid stenosis in patients with head and neck malignanciesQ59344258
Supraclavicular radiation for breast cancer does not increase the 10-year risk of strokeQ63365961
Central Nervous System Complications of Hematopoietic Stem Cell TransplantQ38904785
Nonbacterial Thrombotic Endocarditis: Pathogenesis, Diagnosis, and ManagementQ38921786
Neurologic Complications after Allogeneic Hematopoietic Stem Cell TransplantationQ39063284
Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effectsQ39101607
Nonbacterial thrombotic endocarditis: a reviewQ39760209
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic diseaseQ39946694
Cancer is associated with intraoperative and postprocedural complications and disordersQ40229402
Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapyQ40294108
Poor short-term outcome in patients with ischaemic stroke and active cancerQ40360297
Vascular toxicity associated with chemotherapy for testicular cancerQ40398621
Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal CancerQ40788198
The Impact of the Risk Evaluation Mitigation Strategy for Erythropoiesis-Stimulating Agents on Their Use and the Incidence of Stroke in Medicare Subjects with Chemotherapy-Induced Anemia with Lung and/or Breast Cancers.Q40808482
Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancerQ40810746
Cancer in young adults with ischemic stroke.Q41001331
Clinical features and biological markers of lung cancer-associated strokeQ41010570
Predictors of occult cancer in acute ischemic stroke patientsQ41061795
Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With ChemotherapyQ41175893
Safety of intravenous thrombolysis for acute ischaemic stroke including concomitant neoplastic disease sufferers - experience from PolandQ41344390
Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer CenterQ41483748
In-hospital outcomes of thrombolysis for acute ischemic stroke in patients with primary brain tumorsQ41616566
Concurrent neoadjuvant chemotherapy is an independent risk factor of stroke, all-cause morbidity, and mortality in patients undergoing brain tumor resectionQ43492960
Trends in cancer diagnoses among inpatients hospitalized with strokeQ43535538
Thrombolysis for acute ischemic stroke in patients with cancer: a population study.Q43646711
Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematomaQ43747024
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysisQ24187413
Hematopoietic growth factors: personalization of risks and benefitsQ26866922
Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic reviewQ28069320
Imaging of acute ischemic strokeQ30430085
Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastasesQ30459395
Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging studyQ30690761
Cerebrovascular complications in cancer patientsQ30784799
Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor StudyQ33223549
Leukostasis followed by hemorrhage complicating the initiation of chemotherapy in patients with acute myeloid leukemia and hyperleukocytosis: a clinicopathologic report of four casesQ33327905
Incidence and etiology of cerebrovascular disease in patients with malignancyQ33366898
Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantationQ33383962
Thrombocytopenia in cancer patientsQ33415525
Using direct oral anticoagulants (DOACs) in cancer and other high-risk populationsQ33428160
Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantationQ33434313
Cerebrovascular complications in patients with cancerQ33459157
Neurologic complications of systemic cancer.Q33539282
Granulocyte colony stimulating factor therapy for stroke: A pairwise meta-analysis of randomized controlled trialQ33563023
Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based studyQ33616584
Intracerebral and subarachnoid hemorrhage in patients with cancerQ33698177
Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patientsQ34007066
Echocardiography in nonbacterial thrombotic endocarditis: from autopsy to clinical entityQ34026801
Clues to occult cancer in patients with ischemic strokeQ34416283
Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolismQ34419638
Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal womenQ34460291
Left atrial myxoma with versus without cerebral embolism: length of symptoms, morphologic characteristics, and outcomesQ34608444
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trialQ34727307
Cancer and thromboembolic disease: pathogenic mechanismsQ34863041
The natural history of intravascular lymphomatosisQ35000512
Association between incident cancer and subsequent strokeQ35044297
Extensive experience with dural sinus thrombosisQ35067878
High incidence of ischemic stroke occurrence in irradiated lung cancer patients: a population-based surgical cohort study.Q35141687
Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvementQ35210423
Stroke in patients with cancer: incidence and etiologyQ35796737
Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.Q35994289
Cerebrovascular Complications in Cancer PatientsQ67795745
Arterial thrombosis associated with adjuvant chemotherapy for breast carcinoma: a Cancer and Leukemia Group B StudyQ69248287
Carotici Artery Disease Following ExternalCervical IrradiationQ70966302
Central nervous system leukostasis in patients with leukemias and lymphomasQ71168624
Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic componentQ72201739
[Nonbacterial thrombotic endocarditis--a study of 171 case reports]Q72852032
Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patientsQ73498749
[Cerebrovascular disease in the cancer patient]Q73506199
Cerebral sinus thrombosis diagnosed by MRI and MR venography in cancer patientsQ73621765
Metastatic hepatocellular carcinoma presenting as epidural hematoma: case reportQ74369829
Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 yearsQ77438110
Intracranial hemorrage due to brain metastases in an Italian HCV patient with hepatocellular carcinomaQ79843591
Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcomeQ81072434
Cerebrovascular complications in patients with cancerQ81241328
Stroke in cancer patients: a risk factor analysisQ83464345
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphomaQ84080334
Chronic kidney disease: Association between ESA use and stroke in patients with CKDQ84190747
Graft-versus-host disease of the CNS after allogeneic bone marrow transplantationQ84378367
Leptomeningeal metastasisQ84476076
Cerebrovascular complications in patients with cancerQ84476100
Stroke and Cancer- A Complicated RelationshipQ86037979
Acute Ischemic Stroke on Cancer Patients, a Distinct Etiology? A Case-Control StudyQ86907763
Stroke and cancer: misfortunes never come singularlyQ87137314
Impact of cancer supportive care pathways compliance on emergency department visits and hospitalizationsQ87901657
Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysisQ36192434
Cancer-Associated Stroke: The Bergen NORSTROKE StudyQ36325941
Recurrent embolic strokes and cardiac valvular disease in a patient with non-small cell adenocarcinoma of lungQ36327302
Stroke in cancer patientsQ36458718
Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancerQ36479390
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart diseaseQ36574237
Stroke risk factor, pattern and outcome in patients with cancerQ36643786
Increased risk of ischemic stroke in cervical cancer patients: a nationwide population-based study.Q36691144
Nonbacterial thrombotic endocarditis in cancer patients: pathogenesis, diagnosis, and treatmentQ36830577
Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meetingQ36852443
Cerebrovascular disease risk in older head and neck cancer patients after radiotherapyQ36934353
Risk of first and recurrent stroke in childhood cancer survivors treated with cranial and cervical radiation therapyQ36967224
Radiation, atherosclerotic risk factors, and stroke risk in survivors of pediatric cancer: a report from the Childhood Cancer Survivor StudyQ36967228
Chemotherapy and cerebrovascular diseaseQ37135632
Hemorrhagic and ischemic stroke in children with cancerQ37198475
Stroke and cancer: a reviewQ37212290
Risk of cerebrovascular events after neck and supraclavicular radiotherapy: a systematic reviewQ37378188
Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney diseaseQ37438625
Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.Q37459664
New oral anticoagulants and the cancer patient.Q37519054
Colony-stimulating factors for febrile neutropenia during cancer therapyQ37626772
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host diseaseQ37789530
Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patientsQ37815504
Use of recombinant tissue plasminogen activator in cancer patients with acute stroke.Q37969664
Intracranial hemorrhage in patients with cancer.Q38005011
Headache in stroke: a reviewQ38099678
Epidemiology of infections in cancer patientsQ38202569
Fungal infections in cancer patientsQ38202571
Cardiovascular sequelae of radiation therapyQ38209876
Infectious causes of strokeQ38216450
Diagnosis of acute strokeQ38425958
Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort studyQ38427588
The Efficacy and Safety of Granulocyte Colony-Stimulating Factor for Patients with StrokeQ38500840
Cerebral Sinovenous ThrombosisQ38644032
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse OutcomeQ38691137
P275copyright licenseCreative Commons Attribution-NonCommercial-NoDerivativesQ6937225
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectstrokeQ12202
pathophysiologyQ1135939
neoplasmQ1216998
P304page(s)779-796
P577publication date2019-01-02
2019-03-01
P1433published inInternational Journal of OncologyQ6051527
P1476titleCancer-associated stroke: Pathophysiology, detection and management (Review)
P478volume54